270: Your guide to Wegovy’s blockbuster heart study
The Readout Loud
00:00
Denanamab: The Next Biggest Opportunity for the Stock
Denanamab could be a much bigger drug than we think. It's obviously going to take a lot of handholding and logistical things to kind of sort out over the next year. But this drug will launch into next year. And that could be the next leg of the story. I think it's in the stock to some degree, obviously, but that could beThe second biggest driver, which moves the market cap closer to a trillion.
Transcript
Play full episode
